Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting-Reference-Cited by-同舟云学术

Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting

Published:2013-09 Issue:5 Volume:7 Page:399-407
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Simpson Ross J.,Tunceli Kaan,Ramey Dena R.,Neff David R.,Kern David M.,Hsieh Hui-Min,Wertz Debra A.,Stephenson Judith J.,Marrett Elizabeth,Tomassini Joanne E.,Jacobson Terry A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

2. ESC/EAS guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Catapano;Atherosclerosis,2011

3. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations;Genest;Can J Cardiol,2009

4. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines;Grundy;J Am Coll Cardiol,2004

5. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute;Smith;Circulation,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review;Pharmacoepidemiology and Drug Safety;2024-08

2. Efectividad de la polipíldora CNIC en prevención cardiovascular secundaria en el subgrupo de pacientes del estudio NEPTUNO con dosis de atorvastatina de 20 mg;Archivos de Cardiología de México;2024-06-07

3. Evaluation of Statin Indication and Dose Intensification Among Type 2 Diabetic Patients at a Tertiary Hospital;Diabetes, Metabolic Syndrome and Obesity;2024-03

4. Evaluation of statin indication and dose intensification among type 2 diabetic patients at Tikur Anbessa Specialized Hospital;2023-10-17

5. Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study;The Lancet Regional Health - Europe;2023-08